This inventor holds 2 USPTO granted patents. Top assignee: Northwestern University. Active years: 2014-2018.
Company Filing History:
Years Active: 2014-2018
Title: Mark Witschi: Innovator in Anti-Cancer Compounds
Introduction
Mark Witschi is a notable inventor based in Davis, CA (US). He has made significant contributions to the field of anti-cancer research. With a focus on developing therapeutic agents, Witschi has been instrumental in advancing the understanding and treatment of hyperproliferative conditions.
Latest Patents
Witschi holds 2 patents related to anti-cancer compounds. His latest inventions focus on the discovery and therapeutic use of these compounds. In particular, he has developed analogs of the known anti-cancer compound amonafide, along with structurally and functionally related compounds. These innovations aim to provide effective methods for treating various conditions associated with hyperproliferation.
Career Highlights
Mark Witschi is affiliated with Northwestern University, where he continues to engage in groundbreaking research. His work has garnered attention for its potential impact on cancer treatment and patient outcomes.
Collaborations
Witschi has collaborated with esteemed colleagues, including Daniel H Appella and Sui Huang. These partnerships have further enriched his research endeavors and contributed to the advancement of anti-cancer therapies.
Conclusion
Mark Witschi's innovative work in the field of anti-cancer compounds highlights his commitment to improving therapeutic options for patients. His contributions are paving the way for future advancements in cancer treatment.